Company news

Patrys Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

PAT-DX1-NP Localizes to Lymph Node Metastases

January 28, 2018

Entitlement Offer Booklet

January 14, 2018

PAT-DX1 is synergistic with PARP inhibitor

December 10, 2017

Collaboration with WEHI

November 15, 2017

Appendix 4C - Quarterly - 30 September 2017

October 27, 2017

PAB and Garvan Institute of Medical Research Awarded Grant

October 15, 2017

US Patent Granted for Preclinical Candidate PAT-LM1

October 11, 2017

PAT-DX1 Conjugated to Nanoparticles, Targets Tumors

September 17, 2017

PAT-DX1 Active in Pre-clinical Cancer Models

September 13, 2017

Appendix 4E and 2017 Annual Report

August 29, 2017

Appendix 4C - Quarterly - 30 June 2017

July 26, 2017

Patrys Deoxymab 3E10 patent granted in the U.S.

July 12, 2017

PAB Licences Deoxymab 3E10 - nanoparticle IP from Yale

June 12, 2017

Finance Update

April 30, 2017

Appendix 4C - Quarterly - 31 March 2017

April 26, 2017

Deoxymab 3E10 lead candidate confirmed

April 19, 2017

Appendix 4D - Half Year Accounts - 31 December 2016

February 22, 2017

Appendix 4C - Quarterly - 31 December 2016

January 17, 2017

Appendix 4C - Quarterly - 30 September 2016

October 28, 2016

Appendix 4E and 2016 Annual Report

August 30, 2016

Appendix 4C - Quarterly - 30 June 2016

July 27, 2016

Appendix 4C - Quarterly - 31 March 2016

April 20, 2016

Publication on PAT-SM6 Combination Therapy

April 5, 2016

Patrys Provides Update on CEO Position

March 30, 2016

Patrys Acquires Novel Assets from Yale University

March 28, 2016

Appendix 4D - Half Year Accounts - 31 December 2015

February 24, 2016

Appendix 4C - Quarterly - 31 December 2015

February 11, 2016

Appendix 4C - Quarterly - 30 September 2015

February 10, 2016

← Newer news releases

Decks

The 5 newest of 43 decks. Every deck is listed under its year.